Author Archives Vimm

  • Wednesday July 3, 2019 Dr. Michael Potente Angiogenesis & Metabolism Laboratory Max Planck Institute for Heart and Lung ResearchBad Nauheim, Germany “Metabolic regulation of endothelial growth state”  

    READ MORE
  • Monday, June 24, 2019 Matteo Costacurta, MD Peter MacCallum Cancer Centre University of Melbourne Melbourne, Australia “A genome-wide CRISPR screen identifies TOP2B as an acquired druggable vulnerability in the context of IMiD resistance” (Potential implications in multiple myeloma and lymphoma therapy)  

    READ MORE
  • Monday, March 4, 2019 Prof. Scott A. Oakes Professor in the Department of Pathology University of California, San Francisco CA USA “Role of the Unfolded Protein Response in a Highly Secretory Cancer“  

    READ MORE
  • A two-year postdoctoral fellowship is available from March 2019 in newly opened lab of Dr. Martinvalet at VIMM to study the Role of Reactive Oxygen Species (ROS) in cytotoxic immunity against cancer cells. Following the move of his laboratory from the University of Geneva (Switzerland) to the Dept. of Biomedical Sciences and VIMM, University of […]

    READ MORE
  • A 3-year fully funded PhD student position is available in the lab of Dr. Luca Scorrano at VIMM and at the Dept. of Biology of the University of Padua to exploit Opa 1 overexpression in experimental therapy of mitochondrial disorders.  The successful candidate will apply to, and be enrolled in the PhD school of Biosciences […]

    READ MORE
  • A 3-year postdoctoral fellowship is available from October 1st, 2019 in the lab of Dr. Luca Scorrano at VIMM (www.vimm.it) to study the role of the mitochondria-shaping protein Opa1 in cancer. The successful candidate with be part of an ongoing effort to identify and target features caused by Opa1 overexpression in cancer.  The recruited postdoc […]

    READ MORE
  • The Molecular Oncology group directed by Prof. Alimonti at the University of Padua-V.I.M.M is seeking two Postdoctoral fellows. Alimonti lab is interested in understanding how the tumor immune response regulates senescence activation or evasion in cancer.  A major focus of the lab is the development of immunotherapeutic strategies for the clinic.  We are looking for […]

    READ MORE
  • Wednesday, February 13, 2019 Kris Wood, Ph.D. Assistant Professor Department of Pharmacology and Cancer Biology Duke University Durham, North Carolina, USA “Tumor vulnerabilities associated with dysregulated mitochondria“  

    READ MORE
  • Monday, January 11, 2019 Dr. Laura Cancedda Department of Neuroscience and Brain Technologies  Italian Institute of Technology Genoa, Italy “New therapeutic approaches for Down syndrome“  

    READ MORE
  •   Padua Life Science Lecture Series Wednesday, January 23, 2019 Prof. Jennifer Lippincott-Schwartz  Howard Hughes Medical Institute Janelia Research Campus  Ashburn, Virginia, USA “Emerging imaging technologies to study cell architecture, dynamics and function”  

    READ MORE
(I use my own pagination)s
V.I.M.M. © 2018 - credits